Lapetus Solutions Advocates for Shift from Disease Focus to Aging and Healthy Life Extension A recent paper published in Nature Aging, titled “Implausibility of Radical Life Extension in Humans in…
Insights on Consumer Attitudes Toward Healthy, Sustainable Food Systems The FoodMinds 2024 Conscious Consumption Index (CCI) reveals a growing awareness of healthy and sustainable food systems among consumers. Despite this…
Innovative Lab Services LLC Expands Reach with MLS Technologies Acquisition Innovative Lab Services LLC (ILS), a prominent provider of analytical instrumentation solutions, has announced its acquisition of MLS Technologies, Inc.…
Nielsen IQ (NIQ), the leading consumer research and retail monitoring firm, has unveiled its mid-year Consumer Outlook report, revealing a significant shift in Asia-Pacific consumer behavior towards purposeful consumption. This…
Exscientia Reaches Key Milestones in Two Programs Under Sanofi Collaboration Exscientia has achieved significant progress in two discovery programs under its collaboration with Sanofi, earning $15 million in milestone payments.…
As CarePlus celebrates its 25th anniversary, the Florida-based Medicare Advantage provider is enhancing its plans for 2025, focusing on affordable healthcare and financial wellness. The new offerings aim to improve…
Colossal, a company focused on de-extinction and species preservation, has made significant strides in its efforts to bring back the thylacine, an iconic Australian marsupial that has been extinct since…
The Mary Kay Ash Foundation® has announced $2.4 million in grants to support cancer research and domestic violence shelters across the U.S. Since its founding in 1996, the foundation has…
Eisai’s Rozebalamin® for Injection 25 mg Wins Good Design Award 2024 for Light-Proof Vial Packaging Eisai Co., Ltd. (Tokyo, CEO: Haruo Naito) announced that its amyotrophic lateral sclerosis (ALS) treatment,…
Grifols Achieves Record Score in 2024 S&P Global Corporate Sustainability Assessment Grifols Secures 70 Points, Demonstrating a Seven-Point Improvement Over Previous Year Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a…
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) has announced promising top-line results from a Phase 3 clinical trial assessing the effectiveness of Zepzelca® (lurbinectedin) combined with the PD-L1 inhibitor atezolizumab (Tecentriq®). This…
Qatar-WHO Report: Lessons and Recommendations for Healthier Sporting Events Building on the experiences from the FIFA World Cup Qatar 2022, the State of Qatar and the World Health Organization (WHO)…